PMC:7080117 / 11128-12097
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"281","span":{"begin":0,"end":8},"obj":"Species"},{"id":"282","span":{"begin":331,"end":346},"obj":"Disease"},{"id":"283","span":{"begin":862,"end":878},"obj":"Disease"},{"id":"284","span":{"begin":918,"end":933},"obj":"Disease"},{"id":"285","span":{"begin":943,"end":962},"obj":"Disease"}],"attributes":[{"id":"A281","pred":"tao:has_database_id","subj":"281","obj":"Tax:9606"},{"id":"A282","pred":"tao:has_database_id","subj":"282","obj":"MESH:D012141"},{"id":"A283","pred":"tao:has_database_id","subj":"283","obj":"MESH:D010996"},{"id":"A284","pred":"tao:has_database_id","subj":"284","obj":"MESH:D008206"},{"id":"A285","pred":"tao:has_database_id","subj":"285","obj":"MESH:D011656"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Patients (n = 90)\nDistribution\n Periphery distribution 46 (51%)\n Bilateral involvement 53 (59%)\n Multifocal involvement 62 (69%)\n Unifocal involvement 7 (8%)\nNumber of lobes involved\n 0 21 (23%)\n 1 12 (13%)\n 2 4 (4%)\n 3 13 (14%)\n 4 8 (9%)\n 5 32 (36%)\n More than two lobes involved 53 (59%)\nLobe of lesion distribution\n Left upper lobe 48 (53%)\n Left lower lobe 55 (61%)\n Right upper lobe 48 (53%)\n Right middle lobe 40 (44%)\n Right lower lobe 59 (66%)\n Bilateral upper lobes 40 (44%)\n Bilateral lower lobes 47 (52%)\nPatterns of the lesion\n Ground glass opacification 65 (72%)\n Consolidation 12 (13%)\n Crazy paving pattern 11 (12%)\n Cavitation 0 (0%)\nOther signs in the lesion\n Interlobular septal thickening 33 (37%)\n Linear opacities combined 55 (61%)\n Air bronchogram sign 7 (8%)\nOther findings\n Adjacent pleura thickening 50 (56%)\n Pleural effusion 4 (4%)\n Pericardial effusion 1 (1%)\n Lymphadenopathy 1 (1%)\n Pulmonary emphysema 0 (0%)"}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T41","span":{"begin":331,"end":346},"obj":"Body_part"},{"id":"T42","span":{"begin":358,"end":373},"obj":"Body_part"},{"id":"T43","span":{"begin":385,"end":401},"obj":"Body_part"},{"id":"T44","span":{"begin":413,"end":430},"obj":"Body_part"},{"id":"T45","span":{"begin":442,"end":458},"obj":"Body_part"},{"id":"T46","span":{"begin":833,"end":839},"obj":"Body_part"}],"attributes":[{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma7370"},{"id":"A42","pred":"fma_id","subj":"T42","obj":"http://purl.org/sig/ont/fma/fma7371"},{"id":"A43","pred":"fma_id","subj":"T43","obj":"http://purl.org/sig/ont/fma/fma7333"},{"id":"A44","pred":"fma_id","subj":"T44","obj":"http://purl.org/sig/ont/fma/fma7383"},{"id":"A45","pred":"fma_id","subj":"T45","obj":"http://purl.org/sig/ont/fma/fma7337"},{"id":"A46","pred":"fma_id","subj":"T46","obj":"http://purl.org/sig/ont/fma/fma9583"}],"text":"Patients (n = 90)\nDistribution\n Periphery distribution 46 (51%)\n Bilateral involvement 53 (59%)\n Multifocal involvement 62 (69%)\n Unifocal involvement 7 (8%)\nNumber of lobes involved\n 0 21 (23%)\n 1 12 (13%)\n 2 4 (4%)\n 3 13 (14%)\n 4 8 (9%)\n 5 32 (36%)\n More than two lobes involved 53 (59%)\nLobe of lesion distribution\n Left upper lobe 48 (53%)\n Left lower lobe 55 (61%)\n Right upper lobe 48 (53%)\n Right middle lobe 40 (44%)\n Right lower lobe 59 (66%)\n Bilateral upper lobes 40 (44%)\n Bilateral lower lobes 47 (52%)\nPatterns of the lesion\n Ground glass opacification 65 (72%)\n Consolidation 12 (13%)\n Crazy paving pattern 11 (12%)\n Cavitation 0 (0%)\nOther signs in the lesion\n Interlobular septal thickening 33 (37%)\n Linear opacities combined 55 (61%)\n Air bronchogram sign 7 (8%)\nOther findings\n Adjacent pleura thickening 50 (56%)\n Pleural effusion 4 (4%)\n Pericardial effusion 1 (1%)\n Lymphadenopathy 1 (1%)\n Pulmonary emphysema 0 (0%)"}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T42","span":{"begin":301,"end":305},"obj":"Body_part"},{"id":"T43","span":{"begin":342,"end":346},"obj":"Body_part"},{"id":"T44","span":{"begin":369,"end":373},"obj":"Body_part"},{"id":"T45","span":{"begin":397,"end":401},"obj":"Body_part"},{"id":"T46","span":{"begin":426,"end":430},"obj":"Body_part"},{"id":"T47","span":{"begin":454,"end":458},"obj":"Body_part"},{"id":"T48","span":{"begin":833,"end":839},"obj":"Body_part"},{"id":"T49","span":{"begin":862,"end":878},"obj":"Body_part"}],"attributes":[{"id":"A42","pred":"uberon_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"},{"id":"A43","pred":"uberon_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"},{"id":"A44","pred":"uberon_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"},{"id":"A45","pred":"uberon_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"},{"id":"A46","pred":"uberon_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"},{"id":"A47","pred":"uberon_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"},{"id":"A48","pred":"uberon_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/UBERON_0000977"},{"id":"A49","pred":"uberon_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/UBERON_0000175"}],"text":"Patients (n = 90)\nDistribution\n Periphery distribution 46 (51%)\n Bilateral involvement 53 (59%)\n Multifocal involvement 62 (69%)\n Unifocal involvement 7 (8%)\nNumber of lobes involved\n 0 21 (23%)\n 1 12 (13%)\n 2 4 (4%)\n 3 13 (14%)\n 4 8 (9%)\n 5 32 (36%)\n More than two lobes involved 53 (59%)\nLobe of lesion distribution\n Left upper lobe 48 (53%)\n Left lower lobe 55 (61%)\n Right upper lobe 48 (53%)\n Right middle lobe 40 (44%)\n Right lower lobe 59 (66%)\n Bilateral upper lobes 40 (44%)\n Bilateral lower lobes 47 (52%)\nPatterns of the lesion\n Ground glass opacification 65 (72%)\n Consolidation 12 (13%)\n Crazy paving pattern 11 (12%)\n Cavitation 0 (0%)\nOther signs in the lesion\n Interlobular septal thickening 33 (37%)\n Linear opacities combined 55 (61%)\n Air bronchogram sign 7 (8%)\nOther findings\n Adjacent pleura thickening 50 (56%)\n Pleural effusion 4 (4%)\n Pericardial effusion 1 (1%)\n Lymphadenopathy 1 (1%)\n Pulmonary emphysema 0 (0%)"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T62","span":{"begin":888,"end":908},"obj":"Disease"},{"id":"T63","span":{"begin":918,"end":933},"obj":"Disease"},{"id":"T64","span":{"begin":953,"end":962},"obj":"Disease"}],"attributes":[{"id":"A62","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0001370"},{"id":"A63","pred":"mondo_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/MONDO_0005833"},{"id":"A64","pred":"mondo_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/MONDO_0004849"}],"text":"Patients (n = 90)\nDistribution\n Periphery distribution 46 (51%)\n Bilateral involvement 53 (59%)\n Multifocal involvement 62 (69%)\n Unifocal involvement 7 (8%)\nNumber of lobes involved\n 0 21 (23%)\n 1 12 (13%)\n 2 4 (4%)\n 3 13 (14%)\n 4 8 (9%)\n 5 32 (36%)\n More than two lobes involved 53 (59%)\nLobe of lesion distribution\n Left upper lobe 48 (53%)\n Left lower lobe 55 (61%)\n Right upper lobe 48 (53%)\n Right middle lobe 40 (44%)\n Right lower lobe 59 (66%)\n Bilateral upper lobes 40 (44%)\n Bilateral lower lobes 47 (52%)\nPatterns of the lesion\n Ground glass opacification 65 (72%)\n Consolidation 12 (13%)\n Crazy paving pattern 11 (12%)\n Cavitation 0 (0%)\nOther signs in the lesion\n Interlobular septal thickening 33 (37%)\n Linear opacities combined 55 (61%)\n Air bronchogram sign 7 (8%)\nOther findings\n Adjacent pleura thickening 50 (56%)\n Pleural effusion 4 (4%)\n Pericardial effusion 1 (1%)\n Lymphadenopathy 1 (1%)\n Pulmonary emphysema 0 (0%)"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T95","span":{"begin":239,"end":242},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T96","span":{"begin":256,"end":258},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T97","span":{"begin":347,"end":349},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T98","span":{"begin":402,"end":404},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T99","span":{"begin":529,"end":531},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"},{"id":"T100","span":{"begin":643,"end":645},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T101","span":{"begin":833,"end":839},"obj":"http://purl.obolibrary.org/obo/UBERON_0000977"},{"id":"T102","span":{"begin":862,"end":878},"obj":"http://purl.obolibrary.org/obo/UBERON_0000175"}],"text":"Patients (n = 90)\nDistribution\n Periphery distribution 46 (51%)\n Bilateral involvement 53 (59%)\n Multifocal involvement 62 (69%)\n Unifocal involvement 7 (8%)\nNumber of lobes involved\n 0 21 (23%)\n 1 12 (13%)\n 2 4 (4%)\n 3 13 (14%)\n 4 8 (9%)\n 5 32 (36%)\n More than two lobes involved 53 (59%)\nLobe of lesion distribution\n Left upper lobe 48 (53%)\n Left lower lobe 55 (61%)\n Right upper lobe 48 (53%)\n Right middle lobe 40 (44%)\n Right lower lobe 59 (66%)\n Bilateral upper lobes 40 (44%)\n Bilateral lower lobes 47 (52%)\nPatterns of the lesion\n Ground glass opacification 65 (72%)\n Consolidation 12 (13%)\n Crazy paving pattern 11 (12%)\n Cavitation 0 (0%)\nOther signs in the lesion\n Interlobular septal thickening 33 (37%)\n Linear opacities combined 55 (61%)\n Air bronchogram sign 7 (8%)\nOther findings\n Adjacent pleura thickening 50 (56%)\n Pleural effusion 4 (4%)\n Pericardial effusion 1 (1%)\n Lymphadenopathy 1 (1%)\n Pulmonary emphysema 0 (0%)"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T123","span":{"begin":0,"end":17},"obj":"Sentence"},{"id":"T124","span":{"begin":18,"end":30},"obj":"Sentence"},{"id":"T125","span":{"begin":31,"end":64},"obj":"Sentence"},{"id":"T126","span":{"begin":65,"end":97},"obj":"Sentence"},{"id":"T127","span":{"begin":98,"end":131},"obj":"Sentence"},{"id":"T128","span":{"begin":132,"end":161},"obj":"Sentence"},{"id":"T129","span":{"begin":162,"end":186},"obj":"Sentence"},{"id":"T130","span":{"begin":187,"end":199},"obj":"Sentence"},{"id":"T131","span":{"begin":200,"end":212},"obj":"Sentence"},{"id":"T132","span":{"begin":213,"end":223},"obj":"Sentence"},{"id":"T133","span":{"begin":224,"end":236},"obj":"Sentence"},{"id":"T134","span":{"begin":237,"end":247},"obj":"Sentence"},{"id":"T135","span":{"begin":248,"end":260},"obj":"Sentence"},{"id":"T136","span":{"begin":261,"end":300},"obj":"Sentence"},{"id":"T137","span":{"begin":301,"end":328},"obj":"Sentence"},{"id":"T138","span":{"begin":329,"end":355},"obj":"Sentence"},{"id":"T139","span":{"begin":356,"end":382},"obj":"Sentence"},{"id":"T140","span":{"begin":383,"end":410},"obj":"Sentence"},{"id":"T141","span":{"begin":411,"end":439},"obj":"Sentence"},{"id":"T142","span":{"begin":440,"end":467},"obj":"Sentence"},{"id":"T143","span":{"begin":468,"end":500},"obj":"Sentence"},{"id":"T144","span":{"begin":501,"end":533},"obj":"Sentence"},{"id":"T145","span":{"begin":534,"end":556},"obj":"Sentence"},{"id":"T146","span":{"begin":557,"end":594},"obj":"Sentence"},{"id":"T147","span":{"begin":595,"end":619},"obj":"Sentence"},{"id":"T148","span":{"begin":620,"end":651},"obj":"Sentence"},{"id":"T149","span":{"begin":652,"end":671},"obj":"Sentence"},{"id":"T150","span":{"begin":672,"end":697},"obj":"Sentence"},{"id":"T151","span":{"begin":698,"end":739},"obj":"Sentence"},{"id":"T152","span":{"begin":740,"end":776},"obj":"Sentence"},{"id":"T153","span":{"begin":777,"end":806},"obj":"Sentence"},{"id":"T154","span":{"begin":807,"end":821},"obj":"Sentence"},{"id":"T155","span":{"begin":822,"end":859},"obj":"Sentence"},{"id":"T156","span":{"begin":860,"end":885},"obj":"Sentence"},{"id":"T157","span":{"begin":886,"end":915},"obj":"Sentence"},{"id":"T158","span":{"begin":916,"end":940},"obj":"Sentence"},{"id":"T159","span":{"begin":941,"end":969},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Patients (n = 90)\nDistribution\n Periphery distribution 46 (51%)\n Bilateral involvement 53 (59%)\n Multifocal involvement 62 (69%)\n Unifocal involvement 7 (8%)\nNumber of lobes involved\n 0 21 (23%)\n 1 12 (13%)\n 2 4 (4%)\n 3 13 (14%)\n 4 8 (9%)\n 5 32 (36%)\n More than two lobes involved 53 (59%)\nLobe of lesion distribution\n Left upper lobe 48 (53%)\n Left lower lobe 55 (61%)\n Right upper lobe 48 (53%)\n Right middle lobe 40 (44%)\n Right lower lobe 59 (66%)\n Bilateral upper lobes 40 (44%)\n Bilateral lower lobes 47 (52%)\nPatterns of the lesion\n Ground glass opacification 65 (72%)\n Consolidation 12 (13%)\n Crazy paving pattern 11 (12%)\n Cavitation 0 (0%)\nOther signs in the lesion\n Interlobular septal thickening 33 (37%)\n Linear opacities combined 55 (61%)\n Air bronchogram sign 7 (8%)\nOther findings\n Adjacent pleura thickening 50 (56%)\n Pleural effusion 4 (4%)\n Pericardial effusion 1 (1%)\n Lymphadenopathy 1 (1%)\n Pulmonary emphysema 0 (0%)"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T46","span":{"begin":862,"end":878},"obj":"Phenotype"},{"id":"T47","span":{"begin":888,"end":908},"obj":"Phenotype"},{"id":"T48","span":{"begin":918,"end":933},"obj":"Phenotype"},{"id":"T49","span":{"begin":943,"end":962},"obj":"Phenotype"}],"attributes":[{"id":"A46","pred":"hp_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/HP_0002202"},{"id":"A47","pred":"hp_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/HP_0001698"},{"id":"A48","pred":"hp_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/HP_0002716"},{"id":"A49","pred":"hp_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/HP_0002097"}],"text":"Patients (n = 90)\nDistribution\n Periphery distribution 46 (51%)\n Bilateral involvement 53 (59%)\n Multifocal involvement 62 (69%)\n Unifocal involvement 7 (8%)\nNumber of lobes involved\n 0 21 (23%)\n 1 12 (13%)\n 2 4 (4%)\n 3 13 (14%)\n 4 8 (9%)\n 5 32 (36%)\n More than two lobes involved 53 (59%)\nLobe of lesion distribution\n Left upper lobe 48 (53%)\n Left lower lobe 55 (61%)\n Right upper lobe 48 (53%)\n Right middle lobe 40 (44%)\n Right lower lobe 59 (66%)\n Bilateral upper lobes 40 (44%)\n Bilateral lower lobes 47 (52%)\nPatterns of the lesion\n Ground glass opacification 65 (72%)\n Consolidation 12 (13%)\n Crazy paving pattern 11 (12%)\n Cavitation 0 (0%)\nOther signs in the lesion\n Interlobular septal thickening 33 (37%)\n Linear opacities combined 55 (61%)\n Air bronchogram sign 7 (8%)\nOther findings\n Adjacent pleura thickening 50 (56%)\n Pleural effusion 4 (4%)\n Pericardial effusion 1 (1%)\n Lymphadenopathy 1 (1%)\n Pulmonary emphysema 0 (0%)"}